OBJECTIVE: Piwil2, a member of Ago/Piwi gene family containing Piwi and PAZ domains, has been shown to be ectopically expressed in different cancer cells, especially its remarkable expression in cancer stem cells (CSCs), and is also known to be essential for germ line stem cell self-renewal in various organisms. The hypothesis that CSC may hold the key to the central problem of clinical oncology and tumor relapse leads to more anticancer treatment studies. Due to emerging controversies and extreme difficulties in studying of CSC, like the cells using in vivo models, more attempts have expended to establish different in vitro models. However, the progress was slow owing to the problems associated with establishing proper CSC cultures in vitro. To overcome these difficulties, we prompted to establish a novel stable cell line over-expressing Piwil2 to develop a potential proper in vitro CSC model. MATERIALS AND METHODS: In this experimental study, mouse embryonic fibroblasts (MEFs) were isolated and electroporated with a construct containing Piwil2 cDNA under the control of the cytomegalovirus promoter (CMV). Stable transfectants were selected, and the established MEF-Piwil2 cell line was characterized and designated as CSC-like cells using molecular markers. Functional assays, including proliferation, migration, and invasion assays were performed using characterized CSC like cells in serum-free medium. Additionally, MEF-Piwil2 cell density and viability were measured by direct and indirect methods in normoxic and hypoxic conditions. RESULTS: The results of reverse transcriptase-polymerase chain reaction (RT-PCR), western blot, and immunocytochemistry revealed an overexpression for Piwil2 in the transfected Piwil2 cells both in the RNA and protein levels. Furthermore, analysis of the kinetic and stoichiometric parameters demonstrated that the specific growth rate and the yield of lactate per glucose were significantly higher in the MEF-Piwil2 group compared to the MEF cells (ANOVA, p< 0.05). Also, analysis of functional assays including migration and invasion assays demonstrated a significantly higher number of migrated and invaded cells in the MEF-Piwil2 compared to that of the MEF cells (ANOVA, p< 0.05). The MEF-Piwil2 cells tolerated hypoxia mimetic conditions (CoCl2 ) with more than 95% viability. CONCLUSION: According to the molecular and functional studies, it has been realized that Piwil2 plays a key role(s) in tumor initiation, progression and metastasis. Therefore, Piwil2 can be used not only as a common biomarker for tumor, but also as a target for the development of new anticancer drug. Finally, the main outcome of our study was the establishment of a novel CSC-like in vitro model which is expected to be utilized in understanding the complex roles played by CSC in tumor maintenance, metastasis, therapy resistance or cancer relapse.
OBJECTIVE:Piwil2, a member of Ago/Piwi gene family containing Piwi and PAZ domains, has been shown to be ectopically expressed in different cancer cells, especially its remarkable expression in cancer stem cells (CSCs), and is also known to be essential for germ line stem cell self-renewal in various organisms. The hypothesis that CSC may hold the key to the central problem of clinical oncology and tumor relapse leads to more anticancer treatment studies. Due to emerging controversies and extreme difficulties in studying of CSC, like the cells using in vivo models, more attempts have expended to establish different in vitro models. However, the progress was slow owing to the problems associated with establishing proper CSC cultures in vitro. To overcome these difficulties, we prompted to establish a novel stable cell line over-expressing Piwil2 to develop a potential proper in vitro CSC model. MATERIALS AND METHODS: In this experimental study, mouse embryonic fibroblasts (MEFs) were isolated and electroporated with a construct containing Piwil2 cDNA under the control of the cytomegalovirus promoter (CMV). Stable transfectants were selected, and the established MEF-Piwil2 cell line was characterized and designated as CSC-like cells using molecular markers. Functional assays, including proliferation, migration, and invasion assays were performed using characterized CSC like cells in serum-free medium. Additionally, MEF-Piwil2 cell density and viability were measured by direct and indirect methods in normoxic and hypoxic conditions. RESULTS: The results of reverse transcriptase-polymerase chain reaction (RT-PCR), western blot, and immunocytochemistry revealed an overexpression for Piwil2 in the transfected Piwil2 cells both in the RNA and protein levels. Furthermore, analysis of the kinetic and stoichiometric parameters demonstrated that the specific growth rate and the yield of lactate per glucose were significantly higher in the MEF-Piwil2 group compared to the MEF cells (ANOVA, p< 0.05). Also, analysis of functional assays including migration and invasion assays demonstrated a significantly higher number of migrated and invaded cells in the MEF-Piwil2 compared to that of the MEF cells (ANOVA, p< 0.05). The MEF-Piwil2 cells tolerated hypoxia mimetic conditions (CoCl2 ) with more than 95% viability. CONCLUSION: According to the molecular and functional studies, it has been realized that Piwil2 plays a key role(s) in tumor initiation, progression and metastasis. Therefore, Piwil2 can be used not only as a common biomarker for tumor, but also as a target for the development of new anticancer drug. Finally, the main outcome of our study was the establishment of a novel CSC-like in vitro model which is expected to be utilized in understanding the complex roles played by CSC in tumor maintenance, metastasis, therapy resistance or cancer relapse.
Cancer is defined as a diverse range of diseases in
which dysregulated tissue clones grow rapidly in an
uncontrolled manner and spread throughout the surrounding tissues. Several investigations have highlighted that cancer is indeed a complex multistep
process requiring multiple genetic and epigenetic alterations in the expression of oncogenes, tumor-suppressor genes, cell adhesion molecules, DNA repair
genes, genetic instability, telomerase activation, and
cell-cycle regulators in which the accumulation of
mutations in the genes directly control cancerous cell
birth or death (1, 2). Among the heterogeneous populations of cancerous cells, only a tiny subset termed as
cancer stem cells (CSCs) has the capacity to produce
phenotypic heterogeneity in new tumors (3). In general, these cells are defined by two features: i. self-renewal and ii. muti-potency of differentiation (4). It is
obvious that although the CSC hypothesis may not be
true for all tumor types (5, 6), at least in hematopoetic
(7) and some solid tumors (8), including pancreatic
(9), colon (10), breast (11), lung (12), prostate (13),
and brain (14) tumors, a small population of cells can
be isolated in order to self-renew and form well differentiated tumors similar to that of the patient’s tumor
from which they arise.To consider CSCs as one of therapeutic target candidates for cancer, further studies are needed to address complexities and challenges involving their
biological functions, biomarkers, signal pathways,
differentiation regulation, genomics, proteomics, and
CSC-specific molecules in order to isolate and/or
target CSCs with high accuracy. Due to the extreme
difficulties in studying CSC-like cells through in vivo
models, more attempts were made to develop different in vitro model systems. However, despite the
intensive efforts invested into the establishment of a
proper model, to the best of our knowledge, all hitherto introduced systems encountered serious problems. Thus, one of the main targets of this study was
to establish a novel in vitro model for CSCs that can
be used as a way to better understand the molecular
and cellular aspects of tumor development, progression and invasion, therapy resistance, and of course,
developing new anticancer drugs.Recent studies have indicated ectopic expression of
stem cell protein Piwil2, a member of Ago/Piwi gene
family containing Piwi and PAZ domains, in several
cancer cells with its predominant expression in CSCs
(4, 15-19). With this knowledge, we selected Piwil2 as
a causative factor for generation of CSC-like in vitro
model to come up with the objectives of this search.
Materials and Methods
Isolation and culture of mouse embryonic fibroblasts (MEF)
In this experimental study, for MEF isolation,
uteri isolated from 12.5-day-pregnant mice (strain
NMRI from Pasteur Institute, Iran) were washed
with phosphate-buffered saline (PBS). The head
and liver tissues were removed from isolated
embryos. The remaining bodies were washed in
fresh PBS, minced and transferred into a 0.25%
trypsin/1 mM EDTA solution (0.5 ml per embryo),
and then, incubated at 37˚C for 10 minutes. After
trypsinization, an equal amount of medium [dulbecco’s modified eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS)] was added,
followed by pipetting up and down a few times to
help with tissue dissociation. Cells were collected
by centrifugation (1000×g for 5 minutes) and cultured on 100 mm dishes in DMEM (Gibco, Uk)
containing 10% FBS (Gibco, Uk), 50 units/50 mg/
ml penicillin/streptomycin (Gibco, Uk) at 37˚C
with 5% CO2
, as previously described (20).
Transfection
MEFs (in passage 3) were electroporated with
a plasmid carrying an empty vector (pcDNA3) or
encoding Piwil2 (pCDNA3-Piwil2) (15) and pCDNA3 by Neon™ Transfection System (Invitrogen,
USA) according to the manufacturer’s protocol
(pulse voltage: 1, 350V, pulse width: 30 ms, pulse
number: 1, cell density: 5×106
cells/ml, and tip type:
10 μl). Stable MEFs transfectants were selected by
cultivating in medium containing 600 µg/ml of
G418 (geneticin; Gibco, Uk) for 4 weeks. This established cell line was designated as MEF-Piwil2.
RNA extraction and RT-PCR
Total RNA was extracted from MEFs and MEFPiwil2 cells using RNA Isolation Kit (Roche, Germany) according to the manufacturer’s instructions. cDNAs were prepared from 1.5 µg RNA
using M-MuLV Reverse Transcriptase and random primer (Fermentas, USA), then each PCR
amplification was performed with Taq DNA
Polymerase (Cinnagen, Iran). Β2M (beta-2 macroglobulin) housekeeping gene was used as the
control (standard) gene. Primer sequences are
listed in table 1.List of primer sequences used in qRT-PCR
Immunocytochemistry
Cells were grown on chamber slid in a tow-well
plate and washed three time with PBS then fixed in
4% PFA in PBS and permeabilized with 0.5% Triton X-100 (MERCK; Germany) in PBS for 5 minutes. cells were blocked with 5% donkey serum
in PBS for 1 hour at room temperature. Chamber
slides were incubated with rabbit polyclonal antihuman piwil2 (16) antibody at 1:200 dilution for
O/N at 4˚C and then washed with PBS and incubated for 1 hour with fluorescein-conjugated secondary antibody and DAPI (4’, 6-diamidino-2-phenylindole; Jackson; USA) at 1:200 dilutions and
1:1000, respectively. Cells were further washed in
PBS and mounted with vectashield mounting medium and analyzed using fluorescence microscopy
(BX51 Olympus Microscope, Korea).
Western blot
To examine the expression of Piwil2 at the protein level in the transfected cells, standard western blot analysis was performed. Cells were lysed
in lysis buffer (CelLyticTM M cell lysis reagent,
Sigma, USA), and then, total protein contents were
determined by the Bradford method. Proteins (40
µg) were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE)
under reducing conditions and transferred to a
polyvinylidene difluoride membrane (PVDF; Millipore, USA). Membrane was probed with specific
antibodies. Blot was washed and probed with respective secondary peroxidase-conjugated antibodies, and the bands were visualized by enhanced
chemoluminescence (ECL; Najmbiotech, Iran).
The following antibodies were used: rabbit polyclonal anti-humanpiwil2 (16) and mouse monoclonal anti- β-actin (ab8226) (as a loading control).
Primary and secondary antibodies were used at
1:1000 and 1: 2000 dilutions, respectively.
Induction of hypoxia using cobalt chloride
1×105
cells from Piwil2-transfected and MEF
cells were plated in 6 cm cell culture dishes in
DMEM medium containing 10% FBS. Cells were
treated with various concentrations [0 (normoxic),
25, 50, 100, 150 and 200 µM] of CoCl2
(19) (Sigma-Aldrich, USA) for 48 hours. After cells were
trypsinized, they were counted with a hemacytometer. Also, cell viability was quantified.
Sample analysis
Cell viability was determined by the Trypan blue
exclusion method. Both grids of a neubauer haemocytometer slide were loaded with the cell suspension,
while microscopic cell counts were performed on four
large squares of each grid. Glucose and lactate concentrations were enzymatically measured (21) by glucose and lactate assay kits (ChemEnzyme Co., Iran)
according to manufacturer’s protocol.
Statistical analysis
One-way ANOVA was used to compare the
means of the obtained data. Values of p< 0.05
were considered significant. All statistical calculations were carried out with the SPSS version
16 software.
Invasion assay
Cell invasion assays were performed using BD
BioCoat™ Matrigel™ Invasion Chambers (MIC)
(Cat # 354480, 24 well format) consisting of a BD
Falcon™ TC Companion Plate with Falcon Cell
Culture Inserts containing an 8 micron pore size
PET membrane with a thin layer of MATRIGEL
Basement Membrane Matrix. Briefly, 2.5×104
cells/400 µl of DMEM supplemented with 0.01%
insulin transferin selenium (ITS; Gibco, UK) was
plated in the upper chambers and cultured for 24
hours. DMEM with 10% FBS served as a chemoattractant in lower chambers. Cells from the upper surface of the Matrigel layer were removed
by gentle swabbing, while transmigrated cells attached to the membrane were fixed in 4% paraformaldehyde and stained with eosin. The filters
were rinsed with water, excised from the inserts,
and mounted upside-down onto glass slides. Cells, occupying the underside of the filters and the pores,
were counted in non-overlapping fields of the whole
membranes under a light microscope (Zeiss, Germany). Cell invasion was tested in triplicate wells,
on three independent occasions.
Cell wounding and migration assays
MEFs and MEF-Piwil2 Cells were plated at
1.2-1.4×104
/cm2
in DMEM containing 10% FBS
and allowed to grow to confluence. Wounding was performed using a sterile razor blade to
scrape cells off the culture plate, leaving a denuded area and a sharp visible demarcation line
at the wound edge. The wounded monolayers
were rinsed three times with serum-free medium
and were inspected immediately after wounding.
Then, for quantifying migration, sections of the
wounds were selected according to the criteria
described previously (22), marked, and counted.
The areas with technical problems such as extra
lines made by razor blade, incomplete scraping or
deep wounds were not selected as one of the experimental group. The cells in both experimental
groups were incubated for 36 hours. Then, cells
were rinsed with PBS, fixed, and stained using
Diff-Quick kit solutions (International reagents
Corp, Kobe, Japan), and examined under phasecontrast microscopy (Zeiss, Germany). Migrated
cells were counted in sections 500 µm in length,
allowing a 20 µm space from the demarcation line
in order to minimize the possible physical effects
of cell movement resulting from cell proliferation. Statistical analysis was calculated by averaging a mean of 10 sections per test substance for
each experiment. The number of migrated cells
was expressed as mean ± SEM. Statistical significance was evaluated using analysis of variance
with Scheffé’s test and p< 0.05 was considered
statistically significant. The experiments were repeated at least four times in each group (MEF and
MEF-Piwil2) to assess reproducibility.
Results
MEF-Piwil2 generates CSC-like cells
To establish a stable cell line over-expressing
Piwil2 for developing an in vitro model for CSC
culture, we transfected the MEFs designated as
MEF-Piwil2. The cells over-expressed mili (Piwil2)
using a construct containing pCMV-Piwil2cDNA
shown in figure 1.Schematic pcDNA-Piwil2 map used for transfection
of MEFs.The expression of Piwil2 in the transfected stable
cell line at the RNA and protein levels was confirmed
by RT-PCR, western blot, and ICC (immunecytochemistry). Figure 2, panels A-C, exhibited the expression of Piwil2 in the MEF-Piwil2 stable cell line,
while the MEF cells showed no expression.Piwil2 expression in MEF and MEF-Piwil2 using
RT-PCR, Western Blot and Immunocytochemistry methods.
A. RT-PCR (normalized to B2M) analysis showed Piwil2 expression in MEF-Piwil2 cells, while no band was observed for
MEFs. B. Western-blot (β-actin was used as loading control),
and C. Immunocytochemistry of both confirmed the results
obtained by RT-PCR. 1. MEFs, 2. MEF-Piwil2, and 3. H2O.
Measurement of the kinetic and stoichiometric
parameters
The kinetic and stoichiometric parameters are shown
in table 2. The results showed that the yield of lactate
per glucose (Y lac/glc) increased in MEF-Piwil2 cells
more than 10% (ANOVA, p< 0.05) in comparison with
MEF cells culture. The specific growth rate of cancer
cells reached 0.036 1/h. This amount of specific growth rate was 25% higher than MEF cells 0.025 1/h. The
(Y lac/glc) increased about 11% in high level of CoCl2
(200µM) compared to the control culture (MEF-Piwil2
in normoxic conditions) (ANOVA, p< 0.05)).The kinetic and stoichiometric parameters of
MEF-Piwil2 and MEFsSpecific cell growth rate (µ) and the yield (lac/glu) of MEF
and MEF-Piwil2 cells were measured.The growth rate of cells is defined by dx/dt=µx , where the constant " µ" (1/h) is the specific growth rate, " x" is cell density
(cells/ml) and " t" is culture time (hour).Migratory and invasive behaviors were compared between MEF-Piwil2 and MEF cells. As
shown in (Fig 3, panels A and B), both migration
and invasion were dramatically increased in MEFPiwil2 cells compared with MEFs.
Fig 3
Migration (A) and invasion (B) assays in MEF-Piwil2
and MEFs (p< 0.05). A. Migration in MEF-Piwil2 cells demonstrates a significant difference compared to that of MEFs
(111.67 ± 16.07 vs. to 15.34 ± 6.65 for MEF-Piwil2 and MEFs,
respectively). B. Cell invasion indicated a considerable increase
in MEF-Piwil2 (1205.67 ± 242.5 vs. 10 ± 6.9 for MEF-Piwil2
and MEFs, respectively).
Migration (A) and invasion (B) assays in MEF-Piwil2
and MEFs (p< 0.05). A. Migration in MEF-Piwil2 cells demonstrates a significant difference compared to that of MEFs
(111.67 ± 16.07 vs. to 15.34 ± 6.65 for MEF-Piwil2 and MEFs,
respectively). B. Cell invasion indicated a considerable increase
in MEF-Piwil2 (1205.67 ± 242.5 vs. 10 ± 6.9 for MEF-Piwil2
and MEFs, respectively).
Effect of hypoxia condition to cell density of
MEF-Piwil2
The cell density decreased about 58, 72, and
81% in different concentrations of CoCl2
(25, 50,
and 200 µM, respectively) compared with the cells
in the control group (MEF-Piwil2 in normoxic
condition), (ANOVA, p< 0.05) (Fig 4A). However,
the viability remained unchanged after 48 hours of
hypoxic conditions (more than 95%).
Fig 4
Cell density (A), lactate formation (B), and glucose
consumption (C) following hypoxic exposure. Cell growing,
glucose consumption, and lactate production in normoxic
and hypoxic (25, 50, 100, and 200 µM CoCl2
) conditions. As
shown in the panel (A), the number of cells (growing cells)
decreased as results of cobalt augmentation. As shown in the
panel (B), glucose consumption did not increase CoCl2
concentration; however, cell growing decreased (1.09 ± 0.06 for
normoxic condition vs. 1.23 ± 0.007 for hypoxic conditions).
In panel (C), lactate formation elevated with increasing the
hypoxic condition (1.32 ± 0.115 for normoxic condition vs.
1.33 ± 0.089 for hypoxic conditions). Control (MEF-Piwil2
in normoxic condition). In hypoxic condition after 8 hours,
MEF cells were observed to float; therefore, further analysis
was not performed.
Effect of oxygen limitation on MEF-Piwil2
metabolism
Glucose consumption as an indirect method of
cell activity was measured for all experiments.
The similar glucose concentration was measured
for all experiments (about 1.2 g/l). High level of
lactate concentration and lower cell density MEFPiwil2 in hypoxia mimetic conditions (different concentrations of CoCl2
) in comparison with
control (normoxic) condition proved the effect of
DO (Dissolved Oxygen is the amount of oxygen
concentration in solution) on cell energy supplementation. Lactate concentration reached 1.238 g/l
and 1.09 g/l at 200 µM CoCl2
and control culture,
respectively, after 48 hours of cultivation (Fig 4,
panels B, C).Cell density (A), lactate formation (B), and glucose
consumption (C) following hypoxic exposure. Cell growing,
glucose consumption, and lactate production in normoxic
and hypoxic (25, 50, 100, and 200 µM CoCl2
) conditions. As
shown in the panel (A), the number of cells (growing cells)
decreased as results of cobalt augmentation. As shown in the
panel (B), glucose consumption did not increase CoCl2
concentration; however, cell growing decreased (1.09 ± 0.06 for
normoxic condition vs. 1.23 ± 0.007 for hypoxic conditions).
In panel (C), lactate formation elevated with increasing the
hypoxic condition (1.32 ± 0.115 for normoxic condition vs.
1.33 ± 0.089 for hypoxic conditions). Control (MEF-Piwil2
in normoxic condition). In hypoxic condition after 8 hours,
MEF cells were observed to float; therefore, further analysis
was not performed.In oxygen limiting environment (anaerobic metabolism), 2 moles of lactate are produced per mol
of glucose. The pyruvate resulting from the glucolysis is oxidatively decarbonised to acetyl-CoA
and transformed through the Tricarboxylic acid
(TCA)-cycle into water and CO2
. This pathway
results in 30 mol ATP per mol glucose. Moreover, the lactate formation increased as another cell
growth inhibitor. Based on previous papers, the
lactate concentration has an inhibitory effect at
concentrations of 18 mM (23).
Discussion
CSC research owes its importance to the need for
understanding the cell signaling pathways, which
maintains, inflammation, epithelial to mesenchymal transition (EMT), hypoxia and angiogenesis;
however, these homeostatic processes require further study to expand our understanding of cancer
biology and to identify potential therapeutic targets in personalized medicine (24).Previous studies demonstrated multiple biological functions for different members of Piwi family,
like Piwil2. These functions include activities in
germ line stem cell (GSC) self-renewal, cell Cycling, RNA interference (RNAi), chromosomal
remodeling and epigenetic modulation in various
organisms. Moreover, Piwil2 activates pathways
is related to apoptosis (Stat3/Bcl-XL) and proliferation (Stat3/cyclinD1) (4, 15-19, 25). According
to findings, this protein was ectopically expressed
in various developing stages of different cancers,
predominantly in precancerous stem cells (PCSCs) (4, 17) and CSCs (16). However, it is not
clear whether Piwil2 has a role(s) in development
of CSC populations or it is consequence of cancer.
Thus, in the present study, the MEF-Piwil2 cell
line was established, while the effect of Piwil2 expression on its molecular and functional behavior
was investigated. MEF cells were selected as useful primary cell platform in this research because
usage of commercially-available cell lines could
confound our results according to the following
factors: random mutations and their innate inclination to cancerous state (26).Our results confirmed proliferative and anti-apoptotic roles for Piwil2 (increased expression of
PCNA, Stat3, Bcl-X
, and cyclinD1), as previously
reported (4, 15-17, 25). Moreover, the resulting
cell line stably expressing piwil2 demonstrated a
higher expression for CD44 and CD133, whereas
a lower expression for CD24, which all are considered as cancer stem cell biomarkers. Our molecular
data were consistent with Piwil2 reprogramming
role in the emergence or prevalence of cancer stem
cell population (paper in press).The micro-environmental physiology of tumor
is characterized by higher lactate, extracellular
acidosis, low oxygen gradients (hypoxia and anoxia), and glucose deprivation (27). The analysis
of the kinetic and stoichiometric parameters (Table 2) indicated that in normoxic conditions, (medium without CoCl2
) the specific growth rate of
MEF-Piwil2 cells reached 0.036 1/h, which was
25% higher than MEF cells growth rate (ANOVA,
p< 0.05). Moreover, it was found that production
of MEF-Piwil2 cells lactate was considerably
increased in aerobic conditions. Conversion of
glucose to lactic acid in the presence of oxygen
is known as aerobic glycolysis or the 'Warburg effect'. Increased aerobic glycolysis has been observed in cancerous cells (28).
Table 2
The kinetic and stoichiometric parameters of
MEF-Piwil2 and MEFs
Name
MEF cells
MEF-Piwil2 cells
µ (1/h)
0.025
0.036
Specific cell growth rate (µ) and the yield (lac/glu) of MEF
and MEF-Piwil2 cells were measured.
The growth rate of cells is defined by dx/dt=µx , where the constant " µ" (1/h) is the specific growth rate, " x" is cell density
(cells/ml) and " t" is culture time (hour).
acterized by their poorly
vascularized regions (29); therefore, the ability
of malignant cells for surviving in hypoxic conditions is of critical importance. There is increasing evidence showing a link between the ability
of CSCs surviving under hypoxic conditions and
its key role in therapeutic resistance (30). Interestingly, the CSC-like cells in this culture model are
capable of surviving in the hypoxic conditions induced by adding cobalt chloride to the culture media. In the hypoxia mimetic cobalt chloride conditions, the yield of lactate per glucose increased
about 11% in elevated levels of CoCl2
(200µM),
which was significantly higher compared to that of
the control MEF-Piwil2 cells in normoxic conditions (ANOVA, p<0.05).After 48 hours of hypoxia, the viability of MEFPiwil2 cells remained unchanged (more than 95%),
suggesting that they were resistant to hypoxic conditions, a property that makes them a potential candidate for assessing CSC behavior under hypoxic
conditions.Functional assays including migration and invasion assays were also performed under serumfree conditions as described above. The results of
statistical analysis demonstrated a significantly
higher number of migrated and invaded cells in
the MEF-Piwil2 compared to that of MEF cells
(ANOVA, p<0.05). The cells in the MEF-Piwil2
group could survive in the serum-free conditions.
Culture in this medium has been shown to cause
greater chromosomal stability in vitro than in serum-containing medium (31).The in vitro findings are in accordance with our
in vivo observations, which it indicates that MEFPiwil2 cells form primary and metastatic tumor
rapidly within first few weeks after their transplantation into Nude mice, while MEF cells show no
tumor after approximately one year in press).Collectively, considering all molecular and functional data, it is believed that MEF-Piwil2 cells can
be more efficient for research due to their potential
to survive under serum-free conditions. In other
words, the cell line stably expressing Piwil2 could
assume behavior similar to CSCs in terms of their
potential to survive, expand, migrate and invade
in the hypoxia and serum-free conditions which
mimics the niche of CSCs.
Conclusion
Our molecular and functional studies, demonstrated Piwil2 as a key player in the process of tumor initiation, progression and invasion, suggest
that this factor can be used as a common cancer
biomarker, as well as a target for the development
of new anticancer drug. Eventually, the major outcome of this research was the generation of a novel
CSC-like in vitro model with remarkable application in understanding of the complex roles played
by CSC in tumor main-tenance, metastasis, therapy resistance or cancer relapse.
Authors: Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl Journal: Cancer Res Date: 2006-09-21 Impact factor: 12.701
Authors: Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone Journal: Cancer Res Date: 2007-02-01 Impact factor: 12.701
Authors: Ildar V Gainetdinov; Yulia V Skvortsova; Elena A Stukacheva; Oksana S Bychenko; Sofia A Kondratieva; Marina V Zinovieva; Tatyana L Azhikina Journal: PLoS One Date: 2014-11-10 Impact factor: 3.240
Authors: Johannes Pammer; Heidi Rossiter; Martin Bilban; Leopold Eckhart; Maria Buchberger; Laura Monschein; Michael Mildner Journal: Arch Dermatol Res Date: 2020-03-12 Impact factor: 3.017
Authors: Shu Ly Lim; Carmela Ricciardelli; Martin K Oehler; Izza M D De Arao Tan; Darryl Russell; Frank Grützner Journal: PLoS One Date: 2014-06-16 Impact factor: 3.240